In some adolescents and adults, CoQ10 deficiency presents as an isolated mitochondrial myopathy with exercise intolerance, early fatigue, and proximal muscle weakness rather than a full multisystem syndrome. Muscle biopsies in these patients often show reduced CoQ10 content and ragged‑red fibers or other mitochondrial changes, even when brain, heart, and kidneys appear largely spared on standard evaluation. The encouraging piece is that many individuals with CoQ10‑deficient myopathy experience noticeable improvements in exercise capacity, muscle strength, and CK levels after several months of adequately dosed CoQ10 supplementation, highlighting the importance of recognizing this treatable cause of mitochondrial muscle disease early. This medication is commonly used for High Cholesterol.
Lalani SR, Vladutiu GD, Plunkett K, Lotze TE, Adesina AM, Scaglia F. Isolated Mitochondrial Myopathy Associated With Muscle Coenzyme Q10 Deficiency. Arch Neurol. 2005;62(2):317–320. Neergheen V, Chalasani A, Wainwright L, et al. Coenzyme Q10 in the Treatment of Mitochondrial Disease. Journal of Inborn Errors of Metabolism and Screening. 2017;5Sacconi S, Trevisson E, Salviati L, Aymé S, Rigal O, Redondo AG, Mancuso M, Siciliano G, Tonin P, Angelini C, Auré K, Lombès A, Desnuelle C. Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord. 2010 Jan;20(1):44-8. Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):183-8.
Some side effects may be linked to nutrient depletion caused by this medication.
While studies demonstrate statins effectively lower LDL-C and apoB, research suggests they may also reduce CoQ10 levels. This vital antioxidant plays a crucial role in mitochondrial function, and deficiency can impact brain, muscle, kidney, and heart health. CoQ10 supplementation could be a helpful way to mitigate a potential deficiency when taking a statin therapy.